Cargando…

BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor

BACKGROUND: Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus whose genome was cloned as Bacterial Artificial Chromosome (BAC) and exploited as a gene delivery vector for vaccine purposes. Although BoHV-4 genome has been completely sequenced and its open reading frames (ORFs) structurally defined...

Descripción completa

Detalles Bibliográficos
Autores principales: Franceschi, Valentina, Capocefalo, Antonio, Jacca, Sarah, Rosamilia, Alfonso, Cavirani, Sandro, Xu, Fengwen, Qiao, Wentao, Donofrio, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549876/
https://www.ncbi.nlm.nih.gov/pubmed/26307352
http://dx.doi.org/10.1186/s12917-015-0540-4
_version_ 1782387369697083392
author Franceschi, Valentina
Capocefalo, Antonio
Jacca, Sarah
Rosamilia, Alfonso
Cavirani, Sandro
Xu, Fengwen
Qiao, Wentao
Donofrio, Gaetano
author_facet Franceschi, Valentina
Capocefalo, Antonio
Jacca, Sarah
Rosamilia, Alfonso
Cavirani, Sandro
Xu, Fengwen
Qiao, Wentao
Donofrio, Gaetano
author_sort Franceschi, Valentina
collection PubMed
description BACKGROUND: Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus whose genome was cloned as Bacterial Artificial Chromosome (BAC) and exploited as a gene delivery vector for vaccine purposes. Although BoHV-4 genome has been completely sequenced and its open reading frames (ORFs) structurally defined in silico, most of them are not functionally characterized. In BoHV-4 genome two major immediate early genes (IE) are present, IE1 and IE2. IE2 is an essential gene because its removal from the viral genome renders the virus unable to replicate, whereas for IE1 no many functional information are available. RESULTS: In this work, IE1 contribution in initiating and maintaining BoHV-4 lytic replication was assessed generating a recombinant BoHV-4 genome lacking of IE1 gene, BoHV-4ΔIE1. In contrast to BoHV-4IE2 deleted mutant, BoHV-4ΔIE1 infectious replicating viral particles (IRVPs) could be reconstituted following viral DNA electroporation in permissive cells. However the titer of BoHV-4ΔIE1 IRVPs produced into the cell supernatant and BoHV-4ΔIE1 plaques size were reduced respect to BoHV-4 undeleted control. Further the impaired BoHV-4ΔIE1 IRVPs produced into the cell supernatant could be rescued by expressing IE1 gene product in trans, confirming the implication of IE1 in BoHV-4 lytic replication. Next, the possible role of BoHV-4IE1 as bone marrow stromal cell antigen 2 (BST-2) counteracting factor, as hypothesized by IE1 amino-terminal gene product homology with Kaposi Sarcoma Associated Herpesvirus (KSHV) K5, was excluded too. CONCLUSIONS: Although the real function of BoHV-4IE1 is still elusive, a new BoHV-4 genome gene locus as a target site for the insertion of foreign DNA and resulting in the attenuation of the virus has been revealed. These data can be considered of relevance to improve BoHV-4 gene delivery properties. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-015-0540-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4549876
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45498762015-08-27 BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor Franceschi, Valentina Capocefalo, Antonio Jacca, Sarah Rosamilia, Alfonso Cavirani, Sandro Xu, Fengwen Qiao, Wentao Donofrio, Gaetano BMC Vet Res Research Article BACKGROUND: Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus whose genome was cloned as Bacterial Artificial Chromosome (BAC) and exploited as a gene delivery vector for vaccine purposes. Although BoHV-4 genome has been completely sequenced and its open reading frames (ORFs) structurally defined in silico, most of them are not functionally characterized. In BoHV-4 genome two major immediate early genes (IE) are present, IE1 and IE2. IE2 is an essential gene because its removal from the viral genome renders the virus unable to replicate, whereas for IE1 no many functional information are available. RESULTS: In this work, IE1 contribution in initiating and maintaining BoHV-4 lytic replication was assessed generating a recombinant BoHV-4 genome lacking of IE1 gene, BoHV-4ΔIE1. In contrast to BoHV-4IE2 deleted mutant, BoHV-4ΔIE1 infectious replicating viral particles (IRVPs) could be reconstituted following viral DNA electroporation in permissive cells. However the titer of BoHV-4ΔIE1 IRVPs produced into the cell supernatant and BoHV-4ΔIE1 plaques size were reduced respect to BoHV-4 undeleted control. Further the impaired BoHV-4ΔIE1 IRVPs produced into the cell supernatant could be rescued by expressing IE1 gene product in trans, confirming the implication of IE1 in BoHV-4 lytic replication. Next, the possible role of BoHV-4IE1 as bone marrow stromal cell antigen 2 (BST-2) counteracting factor, as hypothesized by IE1 amino-terminal gene product homology with Kaposi Sarcoma Associated Herpesvirus (KSHV) K5, was excluded too. CONCLUSIONS: Although the real function of BoHV-4IE1 is still elusive, a new BoHV-4 genome gene locus as a target site for the insertion of foreign DNA and resulting in the attenuation of the virus has been revealed. These data can be considered of relevance to improve BoHV-4 gene delivery properties. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-015-0540-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-27 /pmc/articles/PMC4549876/ /pubmed/26307352 http://dx.doi.org/10.1186/s12917-015-0540-4 Text en © Franceschi et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Franceschi, Valentina
Capocefalo, Antonio
Jacca, Sarah
Rosamilia, Alfonso
Cavirani, Sandro
Xu, Fengwen
Qiao, Wentao
Donofrio, Gaetano
BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor
title BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor
title_full BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor
title_fullStr BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor
title_full_unstemmed BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor
title_short BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor
title_sort bohv-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549876/
https://www.ncbi.nlm.nih.gov/pubmed/26307352
http://dx.doi.org/10.1186/s12917-015-0540-4
work_keys_str_mv AT franceschivalentina bohv4immediateearly1geneisadispensablegeneanditsproductisnotabonemarrowstromalcellantigen2counteractingfactor
AT capocefaloantonio bohv4immediateearly1geneisadispensablegeneanditsproductisnotabonemarrowstromalcellantigen2counteractingfactor
AT jaccasarah bohv4immediateearly1geneisadispensablegeneanditsproductisnotabonemarrowstromalcellantigen2counteractingfactor
AT rosamiliaalfonso bohv4immediateearly1geneisadispensablegeneanditsproductisnotabonemarrowstromalcellantigen2counteractingfactor
AT caviranisandro bohv4immediateearly1geneisadispensablegeneanditsproductisnotabonemarrowstromalcellantigen2counteractingfactor
AT xufengwen bohv4immediateearly1geneisadispensablegeneanditsproductisnotabonemarrowstromalcellantigen2counteractingfactor
AT qiaowentao bohv4immediateearly1geneisadispensablegeneanditsproductisnotabonemarrowstromalcellantigen2counteractingfactor
AT donofriogaetano bohv4immediateearly1geneisadispensablegeneanditsproductisnotabonemarrowstromalcellantigen2counteractingfactor